LPCN vs TYL · rev $309.5K vs P/E 89, rev $1.26B
Lipocine Inc (LPCN) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported LPCN revenue for 2026-06-30 was $309.5K. Net income was -$6.3M. LPCN currently screens at market cap $19.3M.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
LPCN currently screens at market cap $19.3M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the LPCN and TYL stock pages for the full models.
Not investment advice.